Cardiol Therapeutics
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2265 Upper Middle Rd E Suite 602, Oakvil...Phone Number
(289) 910-0850Website
www.cardiolrx.comRevenue
<$5 MillionStock Symbol
CRDLIndustry
About Cardiol Therapeutics
Cardiol Therapeutics Inc. is a clinical-stage life sciences company dedicated to the research and development of anti-inflammatory and anti-fibrotic therapies aimed at treating heart diseases. The company focuses on conditions such as pericarditis, myocarditis, and heart failure, with a commitment to improving outcomes for patients suffering from these underserved conditions. Their innovative therapies are currently in clinical trials, including the Phase 3 MAVERIC trial for recurrent pericarditis. Cardiol Therapeutics collaborates with leading researchers and clinicians to advance their drug development efforts.Explore more
Cardiol Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cardiol Therapeutics
Compare insights from companies similar to Cardiol Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cardiol Therapeutics Tech Stack
A closer look at the technologies used by Cardiol Therapeutics
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cardiol Therapeutics
Sign Up For FreeTo access detailed company insights
Cardiol Therapeutics Inc. is a clinical-stage life sciences company dedicated to the research and development of anti-inflammatory and anti-fibrotic therapies aimed at treating heart diseases. The company focuses on conditions such as pericarditis, myocarditis, and heart failure, with a commitment to improving outcomes for patients suffering from t... Read More
